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Um novo composto fluorescente de microcistina-LR marcado com criptato de térbio foi
obtido pela conjugação inicial da microcistina-LR com aminoetanotiol, seguido pela reação
com o grupo éster do criptato de térbio. A formação do produto foi acompanhada por
cromatografia líquida de alta eficiência (CLAE) em 238 nm e 310 nm. A presença de microcistina-
LR na molécula marcada foi confirmada através de ensaio com enzima ligada a imunoabsorvente
(ELISA) e por reação protéica com ácido bicincônico. O espectro de luminescência do criptato
e da molécula conjugada também foram confirmados.
A new fluorescent labeled compound of microcystin-LR with terbium cryptate was obtained
by initial conjugation of microcystins-LR with aminoethanethiol followed by the reaction with
the ester group of terbium cryptate. The product formation was followed by high performance
liquid chromatography (HPLC) at 238 nm and 310 nm. The presence of microcystin-LR in the
labeled molecule was confirmed by enzyme linked immunosorbent assay ELISA and by protein
reaction with bicinhonic acid. Luminescence spectra of cryptate and the conjugated molecule
were carried through as well.
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Introduction
Microcystins are a group of stable heptapeptide
hepatotoxins produced by freshwater cyanobacteria genera
that lower the water quality leading to an increase in the risk
of intoxication for animals and humans. Species of genera
Microcystis, Anabaena, Aphanizomenon, Planktothrix
(Oscillatoria), and Nostoc are frequently described as
producers of microcystins.1 The eutrophication of ponds,
rivers and other freshwater ecosystems allows cyanobacteria
to flourish, leading to contamination of the water.2
Microcystins are potent inhibitors of protein phosphatases
1 (PP1) and 2A (PP2A), which are regulatory enzymes present
in the cytosol of mammalian cells.3 The general structure of
microcystins is composed of cyclo-(D-Ala-X-D-MeAsp-Z-
Adda-D-Glu-Mdha), where X and Z could be various kinds
of L-amino acids; D-MeAsp is D-erythro-β-methylaspartic
acid; Mdha is N-methyldehydroalanine; and Adda is the
unusual amino acid 2S,3S,8S,9S-3-amino-9-methoxy-2,6,8-
trimethyl-10-phenyldeca-4E,6E-dienoic acid.4 The most
extensively studied form is microcystin-LR that contains
L-leucine and L-arginine in the two main variant positions.3
More than 60 different analogues of microcystins have been
described and their acute mouse i.p. toxicity (DL50) varies
between 50-600 μg kg-1.1
Contamination of surface drinking water by micro-
cystin-producing cyanobacteria is a probable cause of
primary liver cancer.5 Chronic oral ingestion of a crude
extract of Microcystis suggests that microcystins can cause
tumors after long-term exposure.6 Human mortalities
resulting from oral consumption of cyanotoxins have been
suspected but not confirmed, due the difficulty of obtaining
reliable data regarding vectors and the circumstances that
would confirm the presence of cyanotoxins in human food
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or water supplies.7 Increasing care is being taken in the
consumption of products contaminated with cyanobacteria
toxins, because of the risks involved in consuming food
that contains blue-green algae or water contaminated by
their toxins.8 Recently, an acute case of poisoning of humans
undergoing haemodialysis with water contaminated with
microcystin killed 76 of a total of 131 patients in the city
of Caruaru in Northeast Brazil.7,9,10 As a consequence, a
microcystin limit of 1μg L-1 was established for drinking
water in Brazil.11
Currently, the aim is to develop a fast, inexpensive and
convenient analytical method for detecting microcystins.
Immunological fluorescent methods using antigen,
monoclonal or polyclonal antibody have become a well-
known protocol.12-16 Fluorescent-labeled reagents have been
developed for biological applications. Kim et. al.17
employed a one-step fluorescence immunochromatographic
assay to quantify microcystins using Alexa Fluor 647. A
fluorescent phosphatases enzyme inhibition assay for
microcystin-LR was developed by Fontal et al.3
Complexes with a lanthanide ion, when excited by
ultraviolet (UV) radiation, show long-lasting luminescence
and are excellent light conversion molecular devices,
LCMD’s18 applied in time-resolved microscopy,19
fluorescent lighting,20 UV dosimeters,21 antirefelection
coatings for solar cells,22 and the labeling of biological
assays.23,24
In the search for more sensitive markers, some chelates
of lanthanides had already been obtained and tested in
various biological assay models.25-27 Time-resolved
fluoroimmunometric assay (TR-FIA) is a method based
on the luminescence emission that is measured after a
delay has elapsed from a pulsed excitation, enabling the
short-lived background fluorescence to be excluded.28
Soini et. al.29 labeled anti-rabbit IgG with europium chelate
as a model to detect rabbit IgG for human smooth muscle
myosin in a histological section; Bonin et al.30 used a
complex of europium and samarium for the detection of
diphteria antitoxins in serum using the ELISA method
and Xu et al.31 labeled anti-β-LH and monoclonal anti-β-
FSH antibodies with europium and samarium, respecti-
vely. The use of luminescent lanthanide as a substitute
for labeled enzyme (e.g. horseradish peroxidase - HRP)
in the ELISA method for microcystin detection has been
described by Mehto et al.28 This system uses microcystin-
LR labeled with a europium chelate.
One of the classes of lanthanide complexes that is
increasingly being used in immunological assays is the
cryptates. These compounds are highly stable when
dissolved in water, and have a high coefficient of molar
absorption, a high quantum yield in water solution and
kinetic and thermodynamic stability.32 Europium cryptate
also has been used for labeling DNA33 and antibodies,34
and the Cis-Bio-Schering Company (France) has now put
on the market a kit with trisbipyridine europium cryptate
for labeling biomolecules. Terbium complex has been used
in thin films as very efficient light converters under UV
excitation, where the ligands act as antennas, absorbing
UV radiation and efficiently transferring energy to Tb3+
emitters. The green emission, 5D4 à 7F5, transition is
monitored as function of UV excitation.18 The use of a
terbium cryptate for labeling cyanotoxins, however, has
not been investigated yet.
There is obviously a need to monitor cyanotoxins in
water samples and products that may have previously been
in contact with cyanobacteria.
This paper describes how a new luminescent terbium




The water used was purified by distillation or
deionization followed by purification via Milli-Q water
system (Millipore), producing water with 18.2 MΩ cm
resistivity. All other reagents, where not specified, were
of analytical or liquid chromatographic grade.
Terbium cryptate synthesis
The labels (a), (b) and (c) refer to the intermediate
compounds shown in Figure 1. The synthesis of the cryptates
was achieved by bromination of diethyl 2,6-dimethyl-3,5-
pyridinedicarboxilate (99% Aldrich), via the initiator
1,1'-Azo (cyclohexanecarbonitrile) (98% Aldrich) and
N-bromosuccinimide (NBS, 99% Aldrich) under reflux and
irradiation by a 100 W incandescent lamp to give
2,6-dibromomethyl-3,5-diethyl-dicarboxilate (a). The bromi-
nation of 6,6'-dimethyl-2,2'-bipyridine used benzoyl peroxide
associated with NBS.35,36 In this procedure the product
6,6'-Bis (bromomethyl)-2,2'-bipyridine (b) is obtained in the
pure state after re-crystallization. The ring (c) was synthesized
following the procedure described in the literature.35,37 The
subsequent step was the formation of the cryptate
[Li⊂bpy.bpy.py(CO2Et)2]CO3–. The product (c) was added
to CH3CN(aq) in an atmosphere of N2(g). The product (a) was
dissolved in an aqueous solution of Li2CO3 under reflux.
The cryptate thus formed (d), was purified using HPLC. The
inclusion of the terbium ion in the cryptate was achieved by
single ionic change with Li+ cation and the lanthanide (e).38,39
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The lanthanide cryptate was purified by HPLC and
characterized by UV-VIS and IR spectroscopies and mass
spectrometry. The UV-VIS absorption spectrum for an
ethanolic solution of terbium cryptate (10-5 mol L-1) presented
maximum intensities at 208 nm, 243 nm and 291 nm. The
product analised by IR with KBr disk for transmission
analysis showed the main bands at 3138.2 cm-1, 2938.3
cm-1, 1685.0 cm-1, 1436.1 cm-1, 1206.3 cm-1 and 1130.8
cm-1.38,39 The proposed formulae of the cryptates synthesized
are also consistent with the mass spectrometry results:
[Tb⊂bpy:bpy.py(CO2Et)2 3+] (MS m/z 800 (M+)) and
[Li⊂bpy:bpy:py(CO2Et)2]Br (MS m/z 728 (M+)).38,39
Microcystin-LR-terbium cryptate conjugation
First stage: conjugation of microcystin-LR to amino-
ethanethiol. Microcystin-LR (Sigma) was dissolved in a
mixture of 20 percent methanol and 80 percent 100 mmol
L-1 phosphate buffer (pH 7.0) to a final concentration of 5.0
mg mL-1 and it was maintained at –20 oC. In the first stage
of conjugation, 13.9 mg of 2-aminoethanethiol hydro-
chloride (Sigma) was added to 60 μg of microcystin-LR in
a molar excess of 3,000-fold. The reaction was carried out
in a solution of 24 μL of dimethyl sulfoxide (Merck),
18 μL of purified water and 8 μL of 5.0 mol L-1 NaOH. The
mixture was incubated for one hour at 50 ºC under nitrogen,
followed by the addition of 62 μL of concentrated acetic
acid and 496 μL of Trifluoracetic acid 0.1% (pH 1.5) as
suggested by Moorhead et al.40 Before the purification of
conjugated microcystin-LR-aminoethanethiol, a mixture of
equal parts of the reaction and microcystin-LR solution of
the same concentration was injected to verify the retention
times. The conjugate was purified by HPLC, frozen-dried
(ModulyoD, ThermoSavant) and suspended in 200 μL of
50 mmol L-1 NaHCO3, 0.15 mol L-1 NaCl buffer (pH 8.5).
Second stage: conjugation of microcystin-LR- amino-
ethanethiol to terbium cryptate. The reaction was carried
out in molar excess of 25:1 cryptate: microcystin-LR-
aminoethanethiol for a 24-hour period (t
oh – t24h). Purified
terbium cryptate (1.7 mg) was dissolved in 200 μL of 50
mmol L-1 NaHCO3, 0.15 mol L-1 NaCl buffer (pH 8.5)
and mixed with 200 μL of the microcystin-LR-
aminoethanethiol solution and incubated at ambient
temperature for 24 hours.
High-Performance Liquid Chromatography (HPLC)
Microcystin-LR, microcystin-LR-aminoethanethiol,
terbium cryptate and all reactions were analyzed using
HPLC. The system consisted of a Shimadzu (Kyoto, Japan)
LC-10ATvp pump and a column C18 LichroCart with 5 μm
Figure 1. Schematic synthesis of terbium cryptate.
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particle size, 250x4 mm (Merck) attached to a UV detector
(SPDM-10Avp). Samples of 50 μL were injected and
separation was accomplished using a reverse phase gradient
and a mobile phase of acetonitrile: 1.0% (v/v) TFA at rate
of flow of 1.0 mL min-1 at 40 ºC. The linear gradient starting
at 15% (v/v) acetonitrile and increasing to 100% over 35
min and maintained for 40 min. The acetonitrile was then
reduced by 15% for 45 min and kept at this ratio until 55
min had elapsed and afterwards, a new injection was
administered. Detector resolution was set at 1.0 nm and
the reaction monitored at 238 nm and 310 nm. The fractions
of terbium-microcystins-LR conjugation were collected,
pooled, frozen-dried and suspended in 500 μL of purified
water so as it could be used in the fluorescence assays
(luminescence), ELISA and protein reaction.
Luminescence spectroscopy
The fraction corresponding to the terbium cryptate and
the terbium-microcystin-LR conjugated, obtained at the
end of the HPLC purification, were analyzed by emission
spectroscopy. The luminescence spectra were measured
at 300 K using a Jobin Yvon double monochromator model
U-1000 Ramanor attached to a water-cooled RCA
C310340-02 photomultiplier. In this case, a 450 UV Xe
lamp was used as the source of excitation. The registering
and processing of the signal were carried out using a
Spectralink interface to an IBM microcomputer.
Purification of anti-microcystin-LR-KLH antibodies
The affinity column of protein G (HiTrap, Amersham,
London, UK) was stabilized with 5 mL of 20 mmol L-1
phosphate buffer (pH 7.0). Nine milliliters of the rabbit
serum anti-microcystin-LR-KLH were applied in
portions of 0.5 mL and the column washed with 5.0 mL
of the same buffer. The fraction of interest was extracted
with 3.0 mL of 0.1 mol L-1 glicina-HCl buffer (pH 2.7)
directly into a tube that contained 0.3 mL of 0.1 mol
L-1 tris-HCl buffer (pH 9.0). The solution of IgG was
reduced to a volume of approximately 200 μL using a
Centricon tube of 30 KD. The final concentration of
antibodies was determined by the total protein analysis.41
Competitive indirect ELISA
The assay used was developed by Karnikowski for
analysis of microcystins.42 The aqueous fraction of terbium-
microcystins-LR conjugation and the fraction corresponding
to the terbium cryptate obtained at the end of the HPLC
purification were diluted in 1/10 in the same buffer used
for microcystin-LR standards. A blank of water and buffer
was utilized. All samples and standards were analysed three
times. This assay is an indirect competitive enzyme
immunoassay on a 96-well microtiter plate (Maxisorp,
Nunc, Roskilde, Denmark) coated with microcystin-LR-
ovoalbumin. The standard curve was achieved with
microcystin-LR solutions of 0.16, 1.6, 5.0 and 10.0 μg L-1.
In summary, 50 μL of a solution of the equal parts of sample
or microcystin-LR standard with the antibody were
incubated for 90 min at 37 ºC and pipetted into the well
and incubated for 2 hours at ambient temperature. The wells
were emptied and washed three times with 200 μL of 15
mmol L-1 phosphate buffer -0.05% Tween (pH 7.2). A 50
μL aliquot of polyclonal anti-rabbit IgG (whole molecule)–
Peroxidase from goat (Sigma-Aldrich Co.) diluted 1 : 2,000
was added and incubated for another 90 min at 37 ºC. The
wells were washed again. An aliquot of 50 μL of substrate
o-phenilenediamine (OPD, Sigma ) was added to each well
and incubated for 10 min at ambient temperature and
protected from light. Finally, 50 μL of a 3.0 mol L-1
hydrochloric solution was added to stop the reaction and
the absorbance immediately recorded at 492 nm using a
microplate reader ( EIA/ELISA reader mod. 2550, Biolab).
Protein analysis
The aqueous fraction of terbium-microcystin-LR
conjugation and terbium cryptate obtained at the end of
HPLC purification were tested for the protein reaction




No peak was detected in the HPLC analysis at the
wavelengths of 238 nm and 310 nm after injection of 50
μL of bicarbonate buffer and aminoethanethiol used for
the conjugation of microcistin-LR to terbium cryptate.
The microcystin-LR standard, when injected separately,
showed a peak at 238 nm after 22.6 min and no peak at
310 nm. The chromatogram of a mixture of equal parts of
microcystin-LR and microcystin-LR-aminoethanethiol
after reaction (1 hour, 50 ºC) showed two peaks at 238
nm, one within 22.6 min and another after 21.5 min
respectively, showing good separation under analytical
test conditions (Figure 2). The injection of the reactional
mixture microcystin-LR-aminoethanethiol (t24h) alone
confirmed the appearance of only one peak after 21.5 min
(data not shown).
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Purified terbium cryptate dissolved in a NaHCO3 buffer
showed a main peak after 18.6 min at 238 nm and 310 nm
(data not shown). The same retention times of the isolated
products, terbium cryptate and microcystin-LR-
aminoethanethiol, were observed at the beginning of the
conjugation, t
oh (Figure 3). A small peak after 15.9 min
was also observed at the beginning of the conjugation at
238 nm and also at 310 nm.
After 24 h of reaction (t24h) a sharp peak was observed
within 15.9 min and an slightly less intense peak after
18.6 min (Figure 4).
The luminescence spectra of the isolated fractions of
terbium-microcystin-LR and terbium cryptate proved to be
characteristic of metallic ion as represented in the Figure 5.
The standard ELISA curve used as standard showed a
good correlation coefficient (r = 0.9346; t = 8.3; p < 0.01)
Figure 2. Chromatogram in gradient reversed-phase HPLC of mixture of
reaction product: (1) microcystin-LR-aminoethanethiol and (2)
microcystin-LR standard.
Figure 3. Chromatogram in gradient reversed-phase HPLC at the begin-
ning of conjugation time (t
oh) of microcystin-LR-aminoethanethiol and
terbium cryptate at 238 nm and 310 nm: (1) Terbium cryptate and (2)
Microcystin-LR-aminoethanethiol.
Figure 4. Chromatogram in gradient reversed-phase HPLC at the final con-
jugation time (t24h) of microcystin-LR-aminoethanethiol and terbium cryptate
at 310 nm: (1) Microcystin-LR-Terbium cryptate and (2) Terbium cryptate.
Figure 5. Emission spectra of microcystin-LR-terbium cryptate fraction ob-
tained in gradient reversed-phase HPLC. Excitation wavelength: 310 nm.
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during the interval from 0.16 μg L-1 to 10.0 μg L-1 (Figure
6). The fraction of microcystin-LR-terbium cryptate
conjugation diluted 1/10, showed a 43.3% inhibition of
antibody response while that corresponding to the terbium
cryptate and the blank did not show inhibition.
The aqueous fraction of terbium-microcystin-LR
conjugation was tested positive for protein using
bicinchonic acid reaction, while the fraction of terbium
cryptate did not.
There is an increasing demand for more sensitive and
inexpensive analytical methods to deal with lower
detection limits and this has given rise to a need for more
sensitive labeling.
A luminescent complex of microcystin-LR-terbium
cryptate was developed for microcystin analysis.
The microcystin-LR was used because it is one of the
most common microcystins28 and is the most hepatotoxic
among microcystins.1 Moreover, it is recommended to
evaluate its concetration in water in various countries,
including Brazil,11 Great Britain and other European
countries43 and the World Health Organization - WHO
also recommended a provisional standard level of 1.0 μg
L-1 for drinking water.44
The cryptate of terbium is very advantageous
because terbium is not so sensitive to aqueous
quenching and the efficient energy transference from
ligand triplet state to the excited metallic state
overcomes the difficulty of the use of terbium chelates
in bioanalytical applications.24 Terbium cryptate
molecule is also of small dimension when compared
with chicken egg albumin (44,000 Da), horseradish
peroxidase (44,000 Da) or IgG antibodies (150,000 Da)
- molecules normally used in immunoassays – thereby
minimizing the possibility of steric hindrance. The
cryptate as biomolecule labeling groups, in contrast of
chelates, has the advantage of being directly conjugated
without a displacement step.33
The microcystin-LR conjugation with amino-
ethanethiol was chosen because it is known that the
reaction occurs with the amino acid methyldehydroalanine
(Mdha) of the toxin40,45 in a position that does not interfere
with the main antigenic region of the molecule, the Adda
amino acid.
The following reaction is proposed for the conjugation
of toxin with terbium cryptate. It is based on the reaction
presented by Metho et al.28 for linking microcystin-LR
with europium chelate (Figure 7).
Figure 6. Semi-log graphic of competitive indirect ELISA of standard
microcystin-LR using anti-microcystin-LR-KHL IgG on a microplate
coated with microcystin-LR- chiken ovoalbumin (n = 3).
Figure 7. Microcystin-LR terbium cryptate conjugation reactions.
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Microcystin-LR reacted, in its entirety, with the low
molecular weight aminoethanethiol, as confirmed by
HPLC: a single peak after 21.5 min (chromatogram not
shown) was detected. Therefore, it could be successfully
resolved from microcystin-LR standard (Figure 2)
allowing it to be recovered for the subsequent reaction.
According to Moorhead et al.,40 the reaction of
aminoethanethiol with the carbonyl group of the Mdha
residue is stronger at a high pH value, producing more
than 95% of intermediate product.
The link inhibition of antibody with microcystin-LR-
chicken ovoalbumin, in the ELISA plate, by the conjugate
(peak 1, Figure 4) demonstrates the immunoreagent
capacity and confirms the microcystin presence in the
structure. In accordance with Lopez et al.34 trisbipyridine
diamine europium cryptate was conjugated to antibody
by the method utilized here without any loss of
immunoreactivity. The structure of the hydrophobic amino
acid Adda, which has the (E) form at the C-6 double bond
is essential for determining antibody specificity13 and was
preserved because the reaction occurred selectively in the
amino acid methyldehydroalanine.40,45
The presence of the toxin in this molecule is
strengthened by a positive protein reaction in this fraction
when using the bicinchonic acid method, whose sensitivity
is for structures with up to four amino acids. The
conjugation of the microcystin-LR is also confirmed by
the luminescence spectra of isolated cryptate and the
microcystin-LR-terbium cryptate fraction.
The terbium criptate used in microcystin-LR
conjugation has a high emission quantum yield in aqueous
solution (q298K =25% at λexc = 320 nm),38 which makes its
use as, e.g, antigen in a ELISA competitive assay through
TR-FIA method, that presents some advantages such as
sensitivity, safety, convenience and ease for automation.46
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